Search results for "Transfection"

showing 10 items of 581 documents

Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy

2007

Reducing body myopathy (RBM) is a rare disorder causing progressive muscular weakness characterized by aggresome-like inclusions in the myofibrils. Identification of genes responsible for RBM by traditional genetic approaches has been impossible due to the frequently sporadic occurrence in affected patients and small family sizes. As an alternative approach to gene identification, we used laser microdissection of intracytoplasmic inclusions identified in patient muscle biopsies, followed by nanoflow liquid chromatography-tandem mass spectrometry and proteomic analysis. The most prominent component of the inclusions was the Xq26.3-encoded four and a half LIM domain 1 (FHL1) protein, expresse…

Models MolecularProteomicsMolecular Sequence DataMuscle ProteinsBiologyTransfectionProteomicsInclusion bodiesMuscular DiseasesmedicineAmino Acid SequenceLaser capture microdissectionInclusion BodiesIntracellular Signaling Peptides and ProteinsCardiac muscleSkeletal muscleGenetic Diseases X-LinkedGeneral MedicineLIM Domain Proteinsmedicine.diseaseCongenital myopathyMolecular biologyFHL1medicine.anatomical_structureMutationMyofibrilResearch Article
researchProduct

Structural requirements for V2 vasopressin receptor proteolytic cleavage.

1999

The ligand-induced proteolytic cleavage of the V2 vasopressin receptor transiently expressed in COS cells was investigated. After incubation of the cell membranes with a photoreactive ligand possessing full agonistic properties for V2 receptors, approximately 90% of the porcine and bovine V2 vasopressin receptors were cleaved in the upper part of transmembrane helix 2 at a heptapeptide sequence conserved in both vasopressin and oxytocin receptors. The oxytocin receptor was completely resistant to proteolysis after binding the same photoreactive ligand, which is only a partial agonist for this receptor. Chimeric V2/oxytocin receptors obtained by transfer of extracellular domains of the oxyto…

Models MolecularReceptors VasopressinDNA ComplementaryTime FactorsProtein ConformationSwineMolecular Sequence DataBiologyLigandsTransfectionBiochemistryArginine vasopressin receptor 2Enzyme-linked receptorCyclic AMPAnimalsHumansPoint Mutation5-HT5A receptorAmino Acid SequenceCloning MolecularReceptorProtease-activated receptor 2Vasopressin receptorArginine vasopressin receptor 1BDose-Response Relationship DrugSequence Homology Amino AcidProteinsOxytocin receptorProtein Structure TertiaryEnzyme ActivationBiochemistryMicroscopy FluorescenceReceptors OxytocinType C PhospholipasesCOS CellsMutagenesis Site-DirectedCattlehormones hormone substitutes and hormone antagonistsAdenylyl CyclasesProtein BindingEuropean journal of biochemistry
researchProduct

Identification and relevance of the CD95-binding domain in the N-terminal region of ezrin.

2003

The CD95 (Fas/APO-1) linkage to the actin cytoskeleton through ezrin is an essential requirement for susceptibility to the CD95-mediated apoptosis in CD4+ T cells. We have previously shown that moesin was not involved in the binding to CD95. Here we further support the specificity of the ezrin/CD95 binding, showing that radixin did not bind CD95. The ezrin region specifically and directly involved in the binding to CD95 was located in the middle lobe of the ezrin FERM domain, between amino acids 149 and 168. In this region, ezrin, radixin, and moesin show 60-65% identity, as compared with the 86% identity in the whole FERM domain. Transfection of two different human cell lines with a green …

Moesinchemical and pharmacologic phenomenaApoptosismacromolecular substancesBiologyBiochemistryEzrinRadixinhemic and lymphatic diseasesHumansfas ReceptorMolecular BiologyActinBinding SitesFERM domainhemic and immune systemsCell BiologyTransfectionActin cytoskeletonPhosphoproteinsActinsCell biologyProtein Structure TertiaryCytoskeletal ProteinsMutationbiological phenomena cell phenomena and immunityBinding domainHeLa CellsProtein BindingSignal TransductionThe Journal of biological chemistry
researchProduct

ASSOCIATION OF RAS-TRANSFECTION WITH CHANGES IN FIBROBLAST MORPHOLOGY AND OXYGEN CONSUMPTION

1991

Morphology (linguistics)medicine.anatomical_structurechemistrymedicinechemistry.chemical_elementTransfectionFibroblastOxygenCell biology
researchProduct

2014

Oligodendrocytes are the myelinating glial cells of the central nervous system. In the course of brain development, oligodendrocyte precursor cells migrate, scan the environment and differentiate into mature oligodendrocytes with multiple cellular processes which recognize and ensheath neuronal axons. During differentiation, oligodendrocytes undergo dramatic morphological changes requiring cytoskeletal rearrangements which need to be tightly regulated. The non-receptor tyrosine kinase Fyn plays a central role in oligodendrocyte differentiation and myelination. In order to improve our understanding of the role of oligodendroglial Fyn kinase, we have identified Fyn targets in these cells. Pur…

MultidisciplinarybiologyIntegrinCellOligodendrocyte differentiationCell migrationTransfectionOligodendrocyteCell biologymedicine.anatomical_structureFYNmedicinebiology.proteinTyrosine kinasePLOS ONE
researchProduct

2015

The NG2 proteoglycan is characteristically expressed by oligodendrocyte progenitor cells (OPC) and also by aggressive brain tumours highly resistant to chemo- and radiation therapy. Oligodendrocyte-lineage cells are particularly sensitive to stress resulting in cell death in white matter after hypoxic or ischemic insults of premature infants and destruction of OPC in some types of Multiple Sclerosis lesions. Here we show that the NG2 proteoglycan binds OMI/HtrA2, a mitochondrial serine protease which is released from damaged mitochondria into the cytosol in response to stress. In the cytosol, OMI/HtrA2 initiates apoptosis by proteolytic degradation of anti-apoptotic factors. OPC in which NG…

NG2 proteoglycanSmall interfering RNAProgrammed cell deathMultidisciplinaryTransfectionMitochondrionBiologymedicine.disease_causeMolecular biologyCell biologynervous systemCell cultureApoptosismedicineOxidative stressPLOS ONE
researchProduct

A combined ex/in vivo assay to detect effects of exogenously added factors in neural stem cells.

2007

We describe a protocol developed/modified by our group for the ex vivo and in vivo assessment of the response to a soluble factor of murine neural stem cells from the adult sub-ventricular zone (SVZ). The procedure includes several experimental options that can be used either independently or in combination. Potential factor effects on self-renewal, survival and proliferation are assayed by means of neurosphere cultures, with the factor administered directly in vitro to the culture plates (Step 1) or infused in vivo immediately before tissue dissociation (Step 3). We also use bromodeoxiuridine (BrdU) retention to label slowly dividing cells in vivo and subsequently perform two different typ…

NeuronsStaining and LabelingStem CellsImmunocytochemistryTransfectionBiologyImmunohistochemistryGeneral Biochemistry Genetics and Molecular BiologyIn vitroNeural stem cellCell biologyCerebral VentriclesMiceBromodeoxyuridineIn vivoNeurosphereAnimalsIntercellular Signaling Peptides and ProteinsStem cellEx vivoCells CulturedNature protocols
researchProduct

Sporogen, S14-95, and S-curvularin, three inhibitors of human inducible nitric-oxide synthase expression isolated from fungi.

2003

The induction of human inducible nitric-oxide synthase (iNOS) expression depends (among other factors) on activation of the signal transducer and activator of transcription 1 (STAT1) pathway. Therefore, the STAT1 pathway may be an appropriate target for the development of inhibitors of iNOS expression. HeLa S3 cells transiently transfected with a gamma-activated site (GAS)/interferon-stimulated response element-driven reporter gene construct were used as the primary screening system. Using this system, three novel inhibitors of interferon-gamma-dependent gene expression, namely, sporogen, S14-95, and S-curvularin, were isolated from different Penicillium species. These three compounds also …

Nitric Oxide Synthase Type IIINitric Oxide Synthase Type IIGene expressionHumansRNA MessengerEnzyme InhibitorsPromoter Regions GeneticCells CulturedNitritesPharmacologyRegulation of gene expressionReporter genebiologyPenicilliumNitric Oxide Synthase Type IIITransfectionCurvularinMolecular biologyNitric oxide synthaseDNA-Binding ProteinsSTAT1 Transcription FactorGene Expression Regulationbiology.proteinSTAT proteinTrans-ActivatorsMolecular MedicineEpoxy CompoundsZearalenoneNitric Oxide SynthaseCell DivisionMolecular pharmacology
researchProduct

Gold Nanoparticle-Assisted Virus Formation by Means of the Delivery of an Oncolytic Adenovirus Genome

2020

[EN] Oncolytic adenoviruses are a therapeutic alternative to treat cancer based on their ability to replicate selectively in tumor cells. However, their use is limited mainly by the neutralizing antibody (Nab) immune response that prevents repeated dosing. An alternative to facilitate the DNA access to the tumor even in the presence of anti-viral Nabs could be gold nanoparticles able to transfer DNA molecules. However, the ability of these nanoparticles to carry large DNA molecules, such as an oncolytic adenovirus genome, has not been studied. In this work, gold nanoparticles were functionalized with different amounts of polyethylenimine to transfer in a safe and efficient manner a large on…

Oncolytic adenovirusVirus oncogènicsOncolytic virusvirusesGeneral Chemical EngineeringGenetic enhancement02 engineering and technologyArticleViruslcsh:ChemistryNanofluids03 medical and health scienceschemistry.chemical_compoundGene therapyPlasmidCIENCIA DE LOS MATERIALES E INGENIERIA METALURGICAnon-viral vectorsGold nanoparticlescancerGeneral Materials ScienceVirotherapyCàncerCancer030304 developmental biologyoncolytic virus0303 health sciencesOncogenic virusesVirotherapyQUIMICA INORGANICATransfection021001 nanoscience & nanotechnologyVirologygene therapyOncolytic viruslcsh:QD1-999chemistrygold nanoparticlesNon-viral vectorsdeliveryvirotherapy0210 nano-technologyDeliveryDNANanomaterials
researchProduct

Bcl-xL and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells

2008

AIM: To explore the role of Bcl-x(L) and Myeloid cell leukaemia (Mcl)-1 for the apoptosis resistance of colorectal carcinoma (CRC) cells towards current treatment modalities. METHODS: Bcl-x(L) and Mcl-1 mRNA and protein expression were analyzed in CRC cell lines as well as human CRC tissue by Western blot, quantitative PCR and immunohistochemistry. Bcl-x(L) and Mcl-1 protein expression was knocked down or increased in CRC cell lines by applying specific siRNAs or expression plasmids, respectively. After modulation of protein expression, CRC cells were treated with chemotherapeutic agents, an antagonistic epidermal growth factor receptor (EGFR1) antibody, an EGFR1 tyrosine kinase inhibitor, …

Organoplatinum CompoundsCell SurvivalCellbcl-X ProteinAntineoplastic AgentsApoptosisBcl-xLAdenocarcinomaBiologyIrinotecanTNF-Related Apoptosis-Inducing LigandDownregulation and upregulationhemic and lymphatic diseasesCell Line TumormedicineHumansRNA Messengerfas ReceptorViability assayneoplasmsColorectal CancerGastroenterologyGeneral MedicineTransfectionFas receptorMolecular biologydigestive system diseasesErbB ReceptorsOxaliplatinmedicine.anatomical_structureProto-Oncogene Proteins c-bcl-2ApoptosisCell cultureCancer researchbiology.proteinMyeloid Cell Leukemia Sequence 1 ProteinCamptothecinFluorouracilColorectal NeoplasmsWorld Journal of Gastroenterology
researchProduct